Pfizer and BioNTech announced that the European Commission (EC) has granted a conditional marketing authorisation (CMA) to Pfizer and BioNTech for COMIRNATY (also known as BNT162b2), for active immunisation to prevent COVID-19 caused by SARS-CoV-2 ...